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1. Introduction 
In general, pharmacological effects of local 
anesthetics may be attributed to their ability to 
reversibly block the propagation of nerve and muscle 
action potentials [I]. At physiologically potent con- 
centrations, local anesthetics (LA) also act as non- 
competitive antagonists of the physiological response 
of post-synaptic nicotinic acetylcholine receptors 
(nAChR) to cholinergic agonists [2], and increase 
agonist binding affinities of nAChR from electric organ 
[2-41. It is postulated that the primary site of LA 
action on nAChR function is at the receptor-coupled 
ionophore [2]. Furthermore, LA-nAChR ionophore 
interactions are thought to accelerate physiological 
desensitization of nAChR, manifest biochemically as 
increased affinity of nAChR for agonist [2]. 
Specific receptors for ol-bungarotoxin (cY-Bgt), a 
potent competitive antagonist at nAChR sites in the 
periphery [S], have been detected in rat central 
nervous system (CNS) membrane preparations [6-IO]. 
The affinity of these central cY-Bgt receptors (cr-BgtR) for 
cholinergic agonists is found to increase on exposure 
to agonist [IO,1 11. Nevertheless, on the basis of incon- 
sistent pharmacological and physiological results, 
uncertainty remains regarding the relationship between 
a-BgtR and authentic nAChR in the CNS, despite a 
wide body of biochemical and histological evidence 
consistent with their identity (see [ 121). 
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Reasoning that if CNS a-BgtR are true nAChR, 
coupled to functional ion channels, LA might be 
expected to cause biochemically measurable increases 
in cu-BgtR affinity for cholinergic agonists, we have 
undertaken a study of the effects of LA on the ability 
of acetylcholine (ACh) to inhibit interaction of a-BgtR 
with 3H-labeled a-Bgt. 
2. Experimental 
Methods for preparation of cr-Bgt, 3H-labeled 
cY-Bgt (cr-[3H]Bgt), and rat brain crude mitochondrial 
fraction membranes containing cu-BgtR, techniques 
for chemical modification of brain a-BgtR disulfides 
with dithiothreitol (DTT), and details of a-[3H]Bgt 
binding assays were as in [ 13-17). The ability of 
ACh to inhibit toxin binding (in the presence of 
100 PM eserine to block acetylcholinesterase activity) 
was measured using two experimental paradigms. Pre- 
incubation assays were conducted by pretreating 
a-BgtR with ACh for 30 min prior to initiation of 
toxin binding by addition of o-[3H]Bgt to 10 nM. 
Coincubation assays were initiated by adding mem- 
brane preparations to solutions containing cr-[3H]Bgt 
and ACh. Effects of LA were assessed using coincuba- 
tion assays where membranes containing a-BgtR were 
pretreated with LA for 30 min prior to addition of 
toxin and ACh. Affinity of a-BgtR for ACh was 
quantitated by determining the concentration of 
ligand necessary to reduce specific cu-[jH]Bgt binding 
(over a 30 min time course) to 50% of control values 
(Ki30). 
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3. Results and discussion 
Local anesthetics, at high concentrations, directly 
inhibit toxin binding to brain crude mitochondrial 
fraction membranes. For exampie, concentrations of 
tetracaine (tet) and dimethisoquin (dim) necessary to 
block 50% of specific OI-[~H] Bgt binding are -200 PM. 
The results suggest that LA interact with a-BgtR at 
the cholinergic active site at these concentrations. 
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Fig.1. Effects of LA on ACh inhibition of a-[ 3H]Bgt binding. 
Specific a-[ ‘H]Bgt binding (%) is plotted against he mole 
concentration of competing ACh (logarithmic scale). Assays 
w?re for native (upper panel) and DTT-treated (lower panel) 
brain membranes. Membranes were either preincubated for 
30 min with ACh prior to the addition of CP[ ‘H]Bgt (*), or 
are added to ACh and a-[ ‘H]Bgt simultaneously (coincuba- 
tion), after exposure for 30 min to 20 PM tetracaine (o), 
20 PM dimethisoquin (A), or buffer without local anesthetic 
(0). Results of an experiment where membranes were added 
to LA, ACh, and a-[ ‘H] Bgt were indistinguishable from 
those for coincubation assay in the absence of LA. 
Whether brain membranes in the native state or 
DTT-treated membranes were used, preincubation 
with cholinergic agonists lead to an increase in the 
affinity of cz-BgtR for agonists, as measured by toxin 
binding-inhibition assays (fig.1). Values Of Ki30 for 
ACh inhibition of cr-[3H]Bgt binding were 5 PM and 
50 PM for preincubation assays using native and 
DTT-treated membranes, respectively. In contrast, 
ACh Ki3’ values were 16 PM and 550 PM for native 
and reduced cu-BgtR, respectively, on coincubation 
assays. These results confirm our earlier observations 
concerning agonist-induced alterations in c+BgtR 
state, which were interpreted as biochemical correlates 
of transformation from resting to desensitized states 
of CNS a-BgtR/nAChR [lo,1 1,171. 
The rate of transformation of cY-BgtR to the high- 
affmity state is apparently accelerated after cu-BgtR 
has been treated with LA at low concentrations, 
where direct competition of LA for c+Bgt binding is 
eliminated (fig.1). Even on coincubation assay, Ki30 
values for ACh inhibition of toxin binding were 5 PM 
for native membranes pretreated with 20 PM dim or 
20 PM tet. Corresponding Ki30 values for AChinterac- 
tion with DTT-treated membranes were 50 PM and 
100 I.IM for reduced a-BgtR preincubated with 20 I.IM 
dim and 20 PM tet, respectively. These LA effects 
were also evident in studies of ACh inhibition of the 
rate of a-[3H]Bgt binding to brain membranes. The 
results may be interpreted as demonstrating LA-induced 
acceleration of transformation of cw-BgtR to a high- 
affinity/desensitized state. 
It may be concluded that the a-BgtR in rat brain 
detected in this study is coupled to an entity that 
possesses ites for high-affinity interaction with LA, 
and that LA occupation of those sites influences 
a-BgtR affinity for cholinergic agonists. The implica- 
tion is that the CNS a-BgtR-LA binding site complex 
is a physiological functional ion-conductance regulator, 
which displays the pharmacological specificity of an 
ACh receptor-ionophore complex. 
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